{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:04:34Z","timestamp":1793261074412,"version":"4.5.0"},"reference-count":54,"publisher":"Informa UK Limited","issue":"24","funder":[{"DOI":"10.13039\/100010544","name":"Exelixis, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010544","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncology"],"published-print":{"date-parts":[[2024,7,29]]},"DOI":"10.1080\/14796694.2024.2352276","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T08:51:46Z","timestamp":1721724706000},"page":"1733-1743","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["STELLAR-303: randomized phase III study of zanzalintinib\u00a0+\u00a0atezolizumab in previously treated metastatic colorectal cancer"],"prefix":"10.1080","volume":"20","author":[{"given":"Anwaar","family":"Saeed","sequence":"first","affiliation":[{"name":"University of Pittsburgh Medical Center (UPMC) & UPMC Hillman Cancer Center","place":["Pittsburgh, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Tabernero","sequence":"additional","affiliation":[{"name":"Vall d'Hebron Hospital Campus & Institute of Oncology (VHIO)","place":["Barcelona, Spain"]},{"name":"IOB-Quiron, UVic-UCC","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Parikh","sequence":"additional","affiliation":[{"name":"Harvard Medical School","place":["Boston, USA"]},{"name":"Massachusetts General Hospital Cancer Center","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Van den Eynde","sequence":"additional","affiliation":[{"name":"Institut Roi Albert II","place":["Brussels, Belgium"]},{"name":"Department of Medical Oncology Cliniques Universitaires St-Luc","place":["Brussels, Belgium"]},{"name":"Institut de Recherche Clinique et Experimentale (Pole MIRO)","place":["Brussels, Belgium"]},{"name":"Universit\u00e9 Catholique de Louvain","place":["Brussels, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meinolf","family":"Karthaus","sequence":"additional","affiliation":[{"name":"Department of Hematology & Oncology","place":["Munich, Germany"]},{"name":"Klinikum Neuperlach\/Klinikum Harlaching","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Gerlinger","sequence":"additional","affiliation":[{"name":"Barts Cancer Institute","place":["UK"]},{"name":"Queen Mary University of London","place":["UK"]},{"name":"Gastrointestinal Cancer Centre","place":["London, UK"]},{"name":"St Bartholomew's Hospital","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Wang","sequence":"additional","affiliation":[{"name":"Exelixis, Inc.","place":["Alameda, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan","family":"Wang","sequence":"additional","affiliation":[{"name":"Exelixis, Inc.","place":["Alameda, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robina","family":"Smith","sequence":"additional","affiliation":[{"name":"Exelixis, Inc.","place":["Alameda, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2277-4157","authenticated-orcid":false,"given":"J Randolph","family":"Hecht","sequence":"additional","affiliation":[{"name":"David Geffen School of Medicine at UCLA","place":["Santa Monica, USA"]},{"name":"Jonsson Comprehensive Cancer Center","place":["Santa Monica, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,7,23]]},"reference":[{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"e_1_3_7_4_1","unstructured":"Cancer stat facts: colorectal cancer [internet]. National Cancer Institute Surveillance Epidemiology and End Results Program; 2022 [cited 2024 Feb 28]. Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/colorect.html."},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.10.003"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61900-X"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1414325"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2214963"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz116"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14204974"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010019"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1500596"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01015"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00197-8"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2020-000813"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.28.3994"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200690"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2022.102480"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.0910"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00772-9"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2026982"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00326-6"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45960-2"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.4_suppl.1"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.04.015"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.18416"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6073-7"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8020203"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1131-x"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02729-7"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.03296"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.101917"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2022.7845"},{"key":"e_1_3_7_34_1","article-title":"XL092, a multi-targeted inhibitor of MET, VEGFR2, AXL and MER with an optimized pharmacokinetic profile","author":"Hsu J","year":"2020","unstructured":"Hsu J, Chong C, Goon L et al. XL092, a multi-targeted inhibitor of MET, VEGFR2, AXL and MER with an optimized pharmacokinetic profile. Poster Session Presented At: 32nd EORTC-NCI-AACR Symposium (Virtual). 2020 Oct 24\u201325.","journal-title":"32nd EORTC-NCI-AACR Symposium (Virtual)."},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11040433"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00813-7"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells11121895"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01489-2"},{"key":"e_1_3_7_39_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20174287"},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-18-1399"},{"key":"e_1_3_7_41_1","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2015.0070"},{"key":"e_1_3_7_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-017-0579-4"},{"key":"e_1_3_7_43_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01656-z"},{"key":"e_1_3_7_44_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02658-z"},{"key":"e_1_3_7_45_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-22-0262"},{"key":"e_1_3_7_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.07.609"},{"key":"e_1_3_7_47_1","unstructured":"A study of XL092 as single-agent and combination therapy in subjects with solid tumors (STELLAR-001) [internet]. ClinicalTrials.gov identifier: NCT03845166. [cited 2024 Feb 28]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03845166."},{"key":"e_1_3_7_48_1","unstructured":"STIVARGA (regorafenib) prescribing information [internet]. Whippany NJ: Bayer HealthCare Pharmaceuticals Inc.. 2020 [cited 2024 Feb 28]. Available from: https:\/\/labeling.bayerhealthcare.com\/html\/products\/pi\/Stivarga_PI.pdf."},{"key":"e_1_3_7_49_1","doi-asserted-by":"publisher","DOI":"10.2174\/156800912798888956"},{"key":"e_1_3_7_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3205"},{"key":"e_1_3_7_51_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.612689"},{"key":"e_1_3_7_52_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2015.00202"},{"key":"e_1_3_7_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2021.118992"},{"key":"e_1_3_7_54_1","doi-asserted-by":"publisher","DOI":"10.1177\/1758835920907504"},{"key":"e_1_3_7_55_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.869010"},{"key":"e_1_3_7_56_1","unstructured":"TECENTRIQ (atezolizumab) prescribing information [internet]. South San Fancisco CA: Genentech Inc.. 2023 [cited 2024 Feb 28]. Available from: www.gene.com\/download\/pdf\/tecentriq_prescribing.pdf"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14796694.2024.2352276","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T08:11:46Z","timestamp":1745827906000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14796694.2024.2352276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,23]]},"references-count":54,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2024,7,29]]}},"alternative-id":["10.1080\/14796694.2024.2352276"],"URL":"https:\/\/doi.org\/10.1080\/14796694.2024.2352276","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,23]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-01-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}